Trustar Capital, the private equity (PE) arm of Chinese alternative investment firm CITIC Capital Holdings, has wrapped up its acquisition of Guilong Pharmaceutical through its China buyout fund, the firm announced without disclosing the financial details.
Continue Reading: Unlock Free Insights!
Stay updated with 3 free articles every month
Access our exclusive newsletters delivered to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in